Canadian Pediatric Neuro-Oncology Standards of Practice.

ependymoma high grade glioma low grade glioma medulloblastoma national strategy pediatric neuro-oncology standards

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 10 08 2020
accepted: 16 11 2020
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 9 1 2021
Statut: epublish

Résumé

Primary CNS tumors are the leading cause of cancer-related death in pediatrics. It is essential to understand treatment trends to interpret national survival data. In Canada, children with CNS tumors are treated at one of 16 tertiary care centers. We surveyed pediatric neuro-oncologists to create a national standard of practice to be used in the absence of a clinical trial for seven of the most prevalent brain tumors in children. This allowed description of practice across the country, along with a consensus. This had a multitude of benefits, including understanding practice patterns, allowing for a basis to compare in future research and informing Health Canada of the current management of patients. This also allows all children in Canada to receive equivalent care, regardless of location.

Identifiants

pubmed: 33415075
doi: 10.3389/fonc.2020.593192
pmc: PMC7783450
doi:

Types de publication

Journal Article

Langues

eng

Pagination

593192

Informations de copyright

Copyright © 2020 Bennett, Erker, Lafay-Cousin, Ramaswamy, Hukin, Vanan, Cheng, Coltin, Fonseca, Johnston, Lo, Zelcer, Alvi, Bowes, Brossard, Charlebois, Eisenstat, Felton, Fleming, Jabado, Larouche, Legault, Mpofu, Perreault, Silva, Sinha, Strother, Tsang, Wilson, Crooks and Bartels.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer SL declared a past co-authorship with the authors to the handling Editor.

Références

Front Oncol. 2015 Oct 21;5:237
pubmed: 26557503
Neuro Oncol. 2019 Feb 22;:
pubmed: 30793186
Pediatr Blood Cancer. 2010 Apr;54(4):635-7
pubmed: 20146217
J Clin Oncol. 2005 Mar 1;23(7):1491-9
pubmed: 15735125
Cancer Treat Rev. 2012 Feb;38(1):27-35
pubmed: 21764221
Childs Nerv Syst. 1997 Jul;13(7):397-405
pubmed: 9298276
Cancer. 2010 Dec 15;116(24):5725-32
pubmed: 20737418
Neuro Oncol. 2020 May 15;22(5):613-624
pubmed: 31889194
Cancer Res. 2008 Nov 1;68(21):8673-7
pubmed: 18974108
Neuro Oncol. 2013 Jun;15(6):788-96
pubmed: 23460321
J Neurooncol. 2019 Nov;145(2):375-383
pubmed: 31621042
Lancet Oncol. 2019 Jul;20(7):1011-1022
pubmed: 31151904
J Clin Oncol. 2005 Oct 20;23(30):7621-31
pubmed: 16234523
Pediatr Neurosurg. 1996;24(3):119-25
pubmed: 8870014
Lancet Oncol. 2016 Apr;17(4):484-495
pubmed: 26976201
Pediatrics. 2010 Apr;125(4):e938-50
pubmed: 20194279
J Clin Oncol. 2020 Apr 10;38(11):1175-1185
pubmed: 32105509
J Clin Oncol. 2009 Jan 20;27(3):385-9
pubmed: 19064966
Acta Neuropathol. 2016 Jun;131(6):821-31
pubmed: 27040285
Oncol Lett. 2013 Jan;5(1):311-315
pubmed: 23255940
Pediatr Blood Cancer. 2016 Nov;63(11):2038-41
pubmed: 27398937
Cancer Res Treat. 2017 Apr;49(2):494-501
pubmed: 27554477
Br J Neurosurg. 2013 Jun;27(3):370-3
pubmed: 23167666
Nat Genet. 2013 Jun;45(6):602-12
pubmed: 23583981
Pediatr Neurol. 2015 Jul;53(1):31-46
pubmed: 26092413
JCO Precis Oncol. 2020 May 20;4:
pubmed: 32923898
Childs Nerv Syst. 2005 Aug;21(8-9):719-24
pubmed: 16133276
Pediatr Blood Cancer. 2014 Jul;61(7):1173-9
pubmed: 24482038
J Neurosurg. 1998 Apr;88(4):695-703
pubmed: 9525716
Lancet Oncol. 2018 Jun;19(6):768-784
pubmed: 29778738
J Clin Oncol. 2018 Jul 1;36(19):1963-1972
pubmed: 29746225
J Pediatr Hematol Oncol. 1999 May-Jun;21(3):203-11
pubmed: 10363853
J Neurooncol. 2005 Mar;72(1):77-84
pubmed: 15803379
Childs Nerv Syst. 2002 Nov;18(11):629-33
pubmed: 12420123
J Neurooncol. 2013 Jun;113(2):285-91
pubmed: 23508296
J Clin Oncol. 2018 Jul 20;36(21):2181-2189
pubmed: 29874137
Acta Neuropathol. 2017 Jan;133(1):5-12
pubmed: 27858204
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):e193-9
pubmed: 23245280
J Neurooncol. 2010 Sep;99(2):243-9
pubmed: 20135195
Neuro Oncol. 2019 Oct 9;21(10):1319-1330
pubmed: 30976811
Oncologist. 2008 Jun;13(6):690-9
pubmed: 18586924
Neurosurgery. 1995 Oct;37(4):655-66; discussion 666-7
pubmed: 8559293
J Clin Oncol. 2014 Mar 20;32(9):886-96
pubmed: 24493713
Int J Radiat Oncol Biol Phys. 1994 Jan 15;28(2):381-6
pubmed: 8276653
Lancet Oncol. 2006 Oct;7(10):813-20
pubmed: 17012043
Oncotarget. 2015 Nov 17;6(36):38827-39
pubmed: 26420814
J Neurooncol. 1989 Jul;7(2):165-77
pubmed: 2550594
Cancer Cell. 2015 May 11;27(5):728-43
pubmed: 25965575
J Pediatr Endocrinol Metab. 2006 Apr;19 Suppl 1:407-12
pubmed: 16700318
Pediatr Blood Cancer. 2009 Jul;52(7):791-5
pubmed: 19165892
Pediatr Blood Cancer. 2008 Aug;51(2):245-50
pubmed: 18386785
J Clin Oncol. 2018 Apr 1;36(10):951-958
pubmed: 29412784
Cancer. 2016 Apr 15;122(8):1261-9
pubmed: 26970559
Lancet Oncol. 2006 Mar;7(3):241-8
pubmed: 16510333
Med Pediatr Oncol. 2003 Apr;40(4):214-8
pubmed: 12555247
J Clin Oncol. 2020 Jan 20;38(3):223-231
pubmed: 31774708
J Clin Oncol. 2004 Aug 1;22(15):3156-62
pubmed: 15284268
Med Pediatr Oncol. 1996 Jul;27(1):8-14
pubmed: 8614396
Neuro Oncol. 2016 Oct;18(10):1442-50
pubmed: 27006176
J Child Neurol. 2018 Aug;33(9):610-620
pubmed: 29848146
J Clin Oncol. 2015 Aug 1;33(22):2464-71
pubmed: 26101244
J Clin Neurosci. 2019 May;63:168-175
pubmed: 30833131
Neuro Oncol. 2014 Mar;16(3):457-65
pubmed: 24335695
Clin Cancer Res. 2019 Dec 15;25(24):7303-7311
pubmed: 31811016
J Neurosurg Pediatr. 2009 Sep;4(3):245-8
pubmed: 19772408
J Clin Endocrinol Metab. 2004 Jan;89(1):81-6
pubmed: 14715831
Neuro Oncol. 2017 Nov 29;19(12):1661-1672
pubmed: 29048505
Acta Neurochir (Wien). 1989;97(3-4):95-106
pubmed: 2655374
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86
pubmed: 30445539
Acta Neuropathol. 2012 Apr;123(4):465-72
pubmed: 22134537
N Engl J Med. 2005 Mar 10;352(10):978-86
pubmed: 15758008
Expert Rev Neurother. 2010 Apr;10(4):515-24
pubmed: 20367205
J Neurosurg. 1997 Mar;86(3):446-55
pubmed: 9046301
Childs Nerv Syst. 2007 Sep;23(9):1041-6
pubmed: 17593372
Childs Nerv Syst. 2014 Jan;30(1):147-54
pubmed: 24162619
Pediatr Blood Cancer. 2008 Aug;51(2):235-40
pubmed: 18381756
J Neurooncol. 2018 May;137(3):645-651
pubmed: 29344823
Pediatr Blood Cancer. 2019 Dec;66(12):e27969
pubmed: 31464041
Front Oncol. 2012 Dec 28;2:205
pubmed: 23293772
Lancet Oncol. 2012 Aug;13(8):838-48
pubmed: 22691720
Pediatr Neurosurg. 1998 Jan;28(1):49-55
pubmed: 9693331
Cancer Cell. 2020 Apr 13;37(4):569-583.e5
pubmed: 32289278
J Clin Oncol. 2019 Dec 1;37(34):3283-3290
pubmed: 31545689
J Child Neurol. 2009 Nov;24(11):1439-45
pubmed: 19841431
Neuro Oncol. 2011 Jun;13(6):669-79
pubmed: 21636711
Cancer Discov. 2020 Jul;10(7):942-963
pubmed: 32238360
Acta Neurochir Suppl. 1995;64:59-63
pubmed: 8748585
Neuro Oncol. 2015 Jan;16 Suppl 10:x1-x36
pubmed: 25542864
Endocrinol Metab Clin North Am. 2008 Mar;37(1):173-93, ix-x
pubmed: 18226736
Lancet Oncol. 2018 Jun;19(6):785-798
pubmed: 29753700
Eur J Cancer. 2012 Feb;48(3):353-9
pubmed: 22023887
Pediatr Blood Cancer. 2016 Sep;63(9):1527-34
pubmed: 27145464
Curr Opin Pediatr. 2007 Aug;19(4):471-9
pubmed: 17630614
J Clin Oncol. 2004 Jul 15;22(14):2877-84
pubmed: 15254056
J Neurooncol. 2013 Dec;115(3):513-20
pubmed: 24085643
Acta Neuropathol Commun. 2016 Feb 29;4:20
pubmed: 26927026
J Pediatr Hematol Oncol. 2010 Jul;32(5):e182-6
pubmed: 20495479
J Clin Oncol. 2012 Jul 20;30(21):2641-7
pubmed: 22665535
J Neurosurg. 2005 Jan;102(1 Suppl):44-52
pubmed: 16206733
Cancer. 2011 Jul 15;117(14):3262-7
pubmed: 21246528
Nat Commun. 2019 Sep 25;10(1):4343
pubmed: 31554817
Cancer Med. 2016 Aug;5(8):1765-75
pubmed: 27228363
Neurology. 2007 Mar 20;68(12):932-8
pubmed: 17372129
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Neuro Oncol. 2017 Oct 1;19(10):1398-1407
pubmed: 28499018
Cancer. 1997 Jul 15;80(2):341-7
pubmed: 9217048
J Clin Oncol. 2019 Apr 20;37(12):974-983
pubmed: 30811284
Lancet Oncol. 2015 Sep;16(9):e470-e477
pubmed: 26370356
Neurosurgery. 2015 Sep;77(3):443-52; discussion 452-3
pubmed: 26083157
J Clin Oncol. 2006 Sep 1;24(25):4202-8
pubmed: 16943538
Neuro Oncol. 2011 Mar;13(3):317-23
pubmed: 21339192
J Neurooncol. 2007 May;82(3):289-95
pubmed: 17120159
Neurosurg Focus. 2010 Apr;28(4):E12
pubmed: 20367356
Pediatr Blood Cancer. 2011 Dec 1;57(6):978-85
pubmed: 21796761
J Clin Oncol. 2016 Oct 10;34(29):3537-3543
pubmed: 27573663
Pituitary. 2006;9(4):323-6
pubmed: 17080265
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Cancer. 2008 Feb 15;112(4):892-9
pubmed: 18098210

Auteurs

Julie Bennett (J)

Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada.

Craig Erker (C)

Division of Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS, Canada.

Lucie Lafay-Cousin (L)

Department of Oncology, Alberta Children's Hospital, Calgary, AB, Canada.

Vijay Ramaswamy (V)

Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada.

Juliette Hukin (J)

Division of Hematology, Oncology and Bone Marrow Transplant, British Columbia Children's Hospital, Vancouver, BC, Canada.

Magimairajan I Vanan (MI)

Department of Oncology, University of Manitoba, Winnipeg, MB, Canada.

Sylvia Cheng (S)

Division of Hematology, Oncology and Bone Marrow Transplant, British Columbia Children's Hospital, Vancouver, BC, Canada.

Hallie Coltin (H)

Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.

Adriana Fonseca (A)

Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada.

Donna Johnston (D)

Division of Hematology/Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.

Andrea Lo (A)

Division of Radiation Oncology and Developmental Radiotherapeutics, BC Cancer Centre, Vancouver, BC, Canada.

Shayna Zelcer (S)

Division of Pediatric Hematology/Oncology, London Health Sciences Centre, London, ON, Canada.

Saima Alvi (S)

Pediatric Oncology, Saskatchewan Cancer Agency, Regina, SK, Canada.

Lynette Bowes (L)

Division of Pediatrics, Memorial University, St. John's, NF, Canada.

Josée Brossard (J)

Division of Pediatric Hematology/Oncology, Universitaire de Sherbrooke, Sherbrooke, QC, Canada.

Janie Charlebois (J)

Division of Pediatric Hematology/Oncology, Universitaire de Sherbrooke, Sherbrooke, QC, Canada.

David Eisenstat (D)

Division of Pediatric Hematology/Oncology & Palliative Care, Stollery Children's Hospital, Edmonton, AB, Canada.

Kathleen Felton (K)

Division of Pediatric Hematology/Oncology, Jim Pattison Children's Hospital, Saskatoon, SK, Canada.

Adam Fleming (A)

Division of Pediatric Hematology/Oncology, McMaster Children's Hospital, Hamilton, ON, Canada.

Nada Jabado (N)

Division of Hematology/Oncology, Montreal Children's Hospital, Montreal, QC, Canada.

Valérie Larouche (V)

Division of Hematology/Oncology, CHU de Quebec, Quebec City, QC, Canada.

Geneviève Legault (G)

Division of Hematology/Oncology, Montreal Children's Hospital, Montreal, QC, Canada.

Chris Mpofu (C)

Division of Pediatric Hematology/Oncology, Jim Pattison Children's Hospital, Saskatoon, SK, Canada.

Sébastien Perreault (S)

Division of Pediatric Neurology, CHU Sainte-Justine, Montreal, QC, Canada.

Mariana Silva (M)

Division of Pediatrics, Queen's University, Kingston, ON, Canada.

Roona Sinha (R)

Division of Pediatric Hematology/Oncology, Jim Pattison Children's Hospital, Saskatoon, SK, Canada.

Doug Strother (D)

Department of Oncology, Alberta Children's Hospital, Calgary, AB, Canada.

Derek S Tsang (DS)

Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada.

Beverly Wilson (B)

Division of Pediatric Hematology/Oncology & Palliative Care, Stollery Children's Hospital, Edmonton, AB, Canada.

Bruce Crooks (B)

Division of Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS, Canada.

Ute Bartels (U)

Division of Neuro-Oncology, The Hospital for Sick Children, Toronto, ON, Canada.

Classifications MeSH